Consumer Goods & Retail Global On demand · 24-48h

Global Children Myopia Control Lens Market Strategic Research Report

Global Children Myopia Control Lens Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Children Myopia Control Lens Market
$1.64B2025
17.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Myopia Control Spectacle Lenses, Orthokeratology, Soft Myopia Control Contact Lenses

By Application: 6 to 12 Years Old, 12 to 18 Years Old

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: HOYA Corporation, ZEISS, EssilorLuxottica, CooperVision, Ovctek, Alpha Corporation, EUCLID, Brighten Optix, Lucid Korea, WeiXing Optical, Contex, Jiangsu Green Stone Optical (SETO), Conant

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 115 pages
Market size 2025
$1.64B
Billion USD
Forecast CAGR
17.4%
2025-2032
Forecast 2032
$5B
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Children Myopia Control Lens market size is predicted to grow from US$ 1,641 million in 2025 to US$ 4,939 million in 2032; it is expected to grow at a CAGR of 17.4% from 2026 to 2032.

Myopia, also called near-sightedness or short-sightedness, is a problem with the focusing ability of the eye. It is when the eye is not able to focus properly on objects in the distance. In this study, Myopia Control Spectacle Lenses, such as ZEISS MyoVision Pro Lenses, HOYA MiyoSmart and Essilor ® Stellest ™ etc. and Myopia Control Contact Lenses (Orthokeratology Lens and Multi-focals (like MiSight)) are focused.

The myopia control lens industry is continuously evolving to address the increasing prevalence of myopia and the growing demand for effective solutions. Several solutions and innovations are being developed and implemented to tackle the challenge of myopia progression.

Specialized Lens Designs: Manufacturers are developing specialized lens designs specifically tailored for myopia control. These lenses employ various optical techniques, such as multifocal optics, peripheral defocus management, and dual-focus designs, to reduce the progression of myopia. These innovative designs aim to optimize visual performance while simultaneously slowing down the elongation of the eye, which is the underlying cause of myopia.

Orthokeratology (Ortho-K): Orthokeratology is a non-surgical method of myopia control that involves wearing specially designed gas-permeable contact lenses overnight. These lenses reshape the cornea temporarily, providing clear vision during the day without the need for glasses or contact lenses. Ortho-K lenses are particularly popular among children and teenagers as they offer a convenient and reversible option for myopia management.

Soft contact lenses offer an alternative option to spectacles for correcting vision. They are made from a flexible clear oxygen permeable material and fit to closely align with the front surface of the eye. Not all of these myopia control soft contact lenses are available in all countries or eye care practices. A further consideration is local regulatory approvals - in the USA for example contact lenses are approved for use by the Federal Drugs and Administration (FDA). Myopia control contact lenses can be prescribed without FDA approval as "off-label" use, but FDA approval provides assurance that a lens has been extensively tested and approved for safety and effectiveness. Currently the CooperVision MiSight 1 day lens is the only myopia control soft contact lens to have FDA approval.

Asia-Pacific is the largest consumption region of Myopia Control Lens, with 87.67% global revenue market share in 2022. China is the country with the largest contribution in the Asia-Pacific region. In 2022, the revenue share of myopia control lenses accounted for 72.79% of the Asia-Pacific region.

Market competition is intense. ZEISS, HOYA Corporation, EssilorLuxottica, CooperVision, Ovctek, Alpha Corporation, EUCLID and Brighten Optix are the leaders of the industry, and hold key technologies and customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future. Of the major players in this market, HOYA hold the largest market share in 2022, followed by ZEISS, EssilorLuxottica and CooperVision. HOYA occupied 30.74% global revenue market share in 2022. ZEISS, EssilorLuxottica and CooperVision occupied 15.70%, 12.07% and 11.34%, respectively.

There are three type of Myopia Control Lens including Myopia Control Spectacle Lenses, Orthokeratology Lens and Soft Contact Lenses.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Children Myopia Control Lens market?

What factors are driving Children Myopia Control Lens market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Children Myopia Control Lens market opportunities vary by end market size?

How does Children Myopia Control Lens break out by Type, by Application?

This report presents a comprehensive overview of the global Children Myopia Control Lens market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Myopia Control Spectacle Lenses
  • Orthokeratology
  • Soft Myopia Control Contact Lenses

Segment by Application

  • 6 to 12 Years Old
  • 12 to 18 Years Old

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Children Myopia Control Lens market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in 6 to 12 Years Old, 12 to 18 Years Old evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Children Myopia Control Lens Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 17.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.64B
2025
Forecast
$5B
2032
CAGR
17.4%
2025–2032
区域
5
global
Key companies
HOYA CorporationZEISSEssilorLuxotticaCooperVisionOvctekAlpha CorporationEUCLIDBrighten Optix
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Myopia Control Spectacle LensesOrthokeratologySoft Myopia Control Contact Lenses
By Application
6 to 12 Years Old12 to 18 Years Old

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Myopia Control Spectacle Lenses
  • 3.1.3 Orthokeratology
  • 3.1.4 Soft Myopia Control Contact Lenses
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 6 to 12 Years Old
  • 4.1.3 12 to 18 Years Old
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 HOYA Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 ZEISS
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 EssilorLuxottica
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 CooperVision
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Ovctek
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Alpha Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 EUCLID
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Brighten Optix
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Lucid Korea
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 WeiXing Optical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Contex
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Jiangsu Green Stone Optical (SETO)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Conant
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Children Myopia Control Lens market?
The global Children Myopia Control Lens market is estimated at US$ 1.64 billion in 2025 (base year) and is projected to reach US$ 4.94 billion by 2032.
How fast is the Children Myopia Control Lens market expected to grow?
The market is expected to grow at a CAGR of 17.4% from 2026 to 2032, expanding from US$ 1.64 billion in 2025 to US$ 4.94 billion in 2032, roughly 3.0 times its base-year value.
What does the Children Myopia Control Lens market cover?
Myopia, also called near-sightedness or short-sightedness, is a problem with the focusing ability of the eye. It is when the eye is not able to focus properly on objects in the distance. In this study, Myopia Control Spectacle Lenses, such as ZEISS MyoVision Pro Lenses, HOYA MiyoSmart and Essilor ® Stellest ™ etc. and Myopia Control Contact Lenses (Orthokeratology Lens and Multi-focals (like MiSight)) are focused.
What are the main segments of the Children Myopia Control Lens market by type?
By type, the market is segmented into Myopia Control Spectacle Lenses, Orthokeratology and Soft Myopia Control Contact Lenses.
Which applications drive demand in the Children Myopia Control Lens market?
Key applications covered include 6 to 12 Years Old and 12 to 18 Years Old.
Who are the key players in the Children Myopia Control Lens market?
Key players profiled include HOYA Corporation, ZEISS, EssilorLuxottica, CooperVision, Ovctek, Alpha Corporation, EUCLID and Brighten Optix, among 13 companies covered in total.
Which regions and countries are covered for Children Myopia Control Lens?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Children Myopia Control Lens market?
What factors are driving Children Myopia Control Lens market growth, globally and by region?
What challenges does the Children Myopia Control Lens market face?
Several solutions and innovations are being developed and implemented to tackle the challenge of myopia progression.
Who should buy the Children Myopia Control Lens market report?
The report is intended for manufacturers and solution providers, distributors and end users in 6 to 12 Years Old and 12 to 18 Years Old, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Children Myopia Control Lens market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.